Daylife Select
A point & click tool to create dynamic content portals. Learn More »
There is no pinned content in this Editor's Picks module.
Click here to learn more about content pinning.
King's College London has formed an alliance with GlaxoSmithKline (GSK) to enable its world-renowned Drug Control Centre to operate a World Anti-Doping Agency (WADA) accredited satellite laboratory during the London 2012 Olympic and Paralympic Games. Full Article at People's Daily Online
An experimental vaccine aimed at shutting down nicotine’s access to the brain is at the centre of a pharmaceutical deal SMOKERS HAVE tried a long list of ways to quit: cold turkey, counselling, gum, patches and more. Full Article at Irish Times
New York, NY (Roche and GlaxoSmithKline) - While in NYC last week, Sally Field and fitness expert Kathy Kaehler urge women to visit Bonehealth.com to get The Bone Healthy Workout and to learn more about ways to improve their bone health. View Photo »
At this point the only information that our office has received has been from the media ... It appears that the vaccine in question was limited to Canada. GlaxoSmithKline said there were no similar reports from other countries.
GlaxoSmithKline, the British drug-maker, will build a £10 million laboratory to test thousands of athletes during the 2012 Olympics and Paralympics under a sponsorship deal announced yesterday by London organisers. Full Article at Times Online
The pharmaceutical company will focus on drug cheats as well as drug discovery for the next two-and-a-half years by providing facilities and equipment to allow King's College London to run drug tests at the Games. Full Article at The Telegraph
New Delhi: Vaccines for H1N1 flu could be available in the country by the end of the month following approvals for human clinical trials by two multinational drug makers, GlaxoSmithKline Plc (GSK) and Baxter International Inc. Full Article at livemint.com
In this undated photo provided by GlaxoSmithKline, vaccine vials are filled automatically in the facility's aseptic core at the GlaxoSmithKline vaccine plant in Marietta, Pa. GlaxoSmithKline is preparing to use this plant for flu vaccines. View Photo »
Pharmaceuticals company GlaxoSmithKline PLC said Tuesday it has advised medical staff in Canada to not use one batch of swine flu vaccines in case they trigger life-threatening allergies. Company spokeswoman Gwenan White said that they issued the advice after reports that one batch of the swine flu vacc...
The fund will award Philadelphia GlaxoSmithKline Opportunity Scholarships of up to $5,000 to Philadelphia residents who have overcome significant adversity, such as serious illness, sexual abuse, domestic violence and personal loss, and are enrolled in... Full Article at Philadelphia Business Journal
LONDON (AP) — British drug maker GlaxoSmithKline PLC will provide anti-doping laboratory equipment to the 2012 Olympics after signing on as the London Games' latest sponsor.The world's No. 2 drug maker will provide the equipment for King's College... Full Article at Newsday
There are no results for this module. Edit this module to change the search term used to query Wikipedia
New York, NY (Roche and GlaxoSmithKline) - While in NYC last week, Sally Field and fitness expert Kathy Kaehler urge women to visit Bonehealth.com to get The Bone Healthy Workout and to learn more about ways to improve their bone health.
View Photo »In this undated photo provided by GlaxoSmithKline, vaccine vials are filled automatically in the facility's aseptic core at the GlaxoSmithKline vaccine plant in Marietta, Pa. GlaxoSmithKline is preparing to use this plant for flu vaccines.
View Photo »In this undated photo released by GlaxoSmithKline PLC, longtime company executive Dominique Limet is shown.
View Photo »The GlaxoSmithKline headquarters are seen in west London, Thursday, Feb. 5, 2009. Europe's largest drugmaker GlaxoSmithKline PLC said Thursday it would cut jobs and costs after fourth quarter net profit fell 10 percent because of higher research and sales spending as well as legal charges.
View Photo »The GlaxoSmithKline headquarters are seen in west London, Thursday, Feb. 5, 2009. Europe's largest drugmaker GlaxoSmithKline PLC said Thursday it would cut jobs and costs after fourth quarter net profit fell 10 percent because of higher research and sales spending as well as legal charges.
View Photo »Joe Cohen, co-inventor of malarial vaccine and GlaxoSmithKline researcher addresses a press conference on November 3, 2009 on the sidelines of the ongoing Multilateral Interventions on Malaria, MIM-PAMC conference in the Kenyan capital, Nairobi.
View Photo »A nurse prepares a shot of the A(H1N1) vaccine (Pandemrix from Glaxo Smith Kline -GSK- laboratory) to a hospital staff member in Istanbul, on November 2, 2009.
View Photo »A nurse prepares a shot of the A(H1N1) vaccine (Pandemrix from Glaxo Smith Kline -GSK- laboratory) to a hospital staff member in Istanbul, on November 2, 2009.
View Photo »A nurse prepares a shot of the A(H1N1) vaccine (Pandemrix from Glaxo Smith Kline -GSK- laboratory) to a hospital staff member in Istanbul, on November 2, 2009.
View Photo »Picture of two flasks allowing to blend several doses, an adjuvant and a antigen, of Pandemrix A(H1N1) vaccine ( from Glaxo Smith Kline -GSK- laboratory), taken at Pellegrin hospital on October 28, 2009 in Bordeaux, southwestern France.
View Photo »Picture of two flasks allowing to blend several doses, an adjuvant and a antigen, of Pandemrix A(H1N1) vaccine ( from Glaxo Smith Kline -GSK- laboratory), taken at Pellegrin hospital on October 28, 2009 in Bordeaux, southwestern France.
View Photo »Picture of two flasks allowing to blend several doses, an adjuvant and a antigen, of Pandemrix A(H1N1) vaccine ( from Glaxo Smith Kline -GSK- laboratory), taken at Pellegrin hospital on October 28, 2009 in Bordeaux, southwestern France.
View Photo »Picture of two flasks allowing to blend several doses, an adjuvant and a antigen, of Pandemrix A(H1N1) vaccine ( from Glaxo Smith Kline -GSK- laboratory), taken at Pellegrin hospital on October 28, 2009 in Bordeaux, southwestern France.
View Photo »Picture of two flasks allowing to blend several doses, an adjuvant and a antigen, of Pandemrix A(H1N1) vaccine ( from Glaxo Smith Kline -GSK- laboratory), taken at Pellegrin hospital on October 28, 2009 in Bordeaux, southwestern France.
View Photo »Picture of a syringue and two flasks allowing to blend several doses, an adjuvant and a antigen, of Pandemrix A(H1N1) vaccine ( from Glaxo Smith Kline -GSK- laboratory), taken at Pellegrin hospital on October 28, 2009 in Bordeaux, southwestern France.
View Photo »A nurse is to give a shot of the A(H1N1) vaccine ( Pandemrix from Glaxo Smith Kline -GSK- laboratory) to a hospital staff member at Pellegrin hospital on October 28, 2009 in Bordeaux, southwestern France.
View Photo »A nurse gives a shot of the A(H1N1) vaccine (Glaxo Smith Kline -GSK- laboratory) to a hospital staff member at Pellegrin hospital on October 28, 2009 in Bordeaux, southwestern France.
View Photo »Women wearing masks are seen at the venue of the Rhythmic Gymnastics World Championships in Ise, Mie prefecture, central Japan September 11, 2009.
View Photo »Girls wearing masks to prevent the H1N1 influenza virus are seen at the venue of the Rhythmic Gymnastics World Championships in Ise, Mie prefecture, central Japan September 11, 2009.
View Photo »Girls wearing masks to prevent the H1N1 influenza virus are seen at the venue of the Rhythmic Gymnastics World Championships in Ise, Mie prefecture, central Japan September 11, 2009.
View Photo »COMMERCIAL PHOTO In this photograph taken by AP Images for MyGoodDeed President and co-founder of MyGoodDeed David Paine, left, makes remarks as other speakers look on during the announcement of the September 11 National Day of Service and Remembrance at the National September 11 Memor...
View Photo »David Paine, left, president and founder of MyGoodDeed, holds a news conference Thursday, Aug. 27, 2009, in New York, to announce and unveil plans to build widespread national support for Sept. 11 as a National Day of Service and Remembrance.
View Photo »In an Aug. 19, 2009 photo, Scott Weinstein, left, and a team of lawyers sits in his Coral Gables, Fla. office discussing the class action lawsuit that he is filing against the makers of denture cream products after several people have come forward to say the cream is causing health pro...
View Photo »In an Aug. 19, 2009 photo, Ronald Beaver sits in his lawyer's office in Coral Gables, Fla. , talking about his lawsuit against the company makes denture cream.
View Photo »In an Aug. 19, 2009 photo, Alice Beaver and her husband, Ronald, discuss health problems they believe are caused by use of a denture cream, in their Coral Gables, Fla. lawyer's office.
View Photo »In this undated photo provided by GlaxoSmithKline, vaccine vials are filled automatically in the facility's aseptic core at the GlaxoSmithKline vaccine plant in Marietta, Pa. GlaxoSmithKline is preparing to use this plant for flu vaccines.
View Photo »At this point the only information that our office has received has been from the media ... It appears that the vaccine in question was limited to Canada. GlaxoSmithKline said there were no similar reports from other countries.
Pharmaceuticals company GlaxoSmithKline PLC said Tuesday it has advised medical staff in Canada to not use one batch of swine flu vaccines in case they trigger life-threatening allergies. Company spokeswoman Gwenan White said that they issued the advice after reports that one batch of the swine flu vacc...
On an ongoing basis (GlaxoSmithKline) is working with Health Canada to ensure that each vaccine lot released to the provinces and territories consistently meets quality and safety standards.
The stockpile will be held in Singapore and will include 400,400 courses of Tamiflu… and 100,000 of GlaxoSmithKline's Relenza antiviral drug.
Four international vaccine manufacturers — Novartis, GlaxoSmithKline (GSK), Sanofi-Aventis and Baxter International — have quoted rates to the government
The number of diabetes cases in the UAE, and rest of the region is very alarming and requires utmost attention from all concerned healthcare authorities and institutions. GlaxoSmithKline has thrown its full support to the Emirates Diabetes Congress as we intend to encourage all stakeholders in the healt...
No prices have been set for the vaccine, Cohen said, though families in Africa may not have to pay anything for it because the [Bill & Melinda] Gates Foundation, UNICEF, WHO and the GAVI Alliance would provide funds. GlaxoSmithKline 'is committed to making sure pricing will never be a barrier to access ...
And most important, the two positive trials will allow Human Genome Sciences and GlaxoSmithKline to file for drug approval with regulatory agencies around the world.
They're still processing and getting more ... There is delay with Sanofi Pasteur vaccine, which is now estimated to be completely shipped by the end of November. GlaxoSmithKline reduced their total output estimate for seasonal influenza vaccine, which accounts for the approximate 3 percent overall reduc...
Yeah, so, GlaxoSmithKline. They're doing alright
We continue to differentiate ourselves from our peer group based on the strength of our financial position, our pipeline of potential first-in-class oncology products, our discovery prowess, and our balanced business strategy anchored in global partnerships with GlaxoSmithKline, Eisai and Johnson & John...
This means the adjuvanted vaccine has been judged safe and effective for use in Canada by both the Canadian manufacturer, GlaxoSmithKline, as well as by the Health Canada regulators.
Four pharmaceutical companies - Sanophy Pastures, Glaxo SmithKline, Baxter and Novartis -- which are lead suppliers abroad have been permitted to sell vaccines in India. They have been asked to submit clinical trial reports to the Drug Controller General of India. In the first phase, health workers who ...
We were very pleased to partner with GlaxoSmithKline in helping them meet increasing demand for their product, and we look forward to working with them in the future
The detail of the distribution and country list is not yet available; however, few countries will be priority to receive the donated vaccines. To date, a pledge for donation of 150 million doses of pandemic vaccines has been made to developing countries, through WHO, from two companies, Glaxo Smith Klin...
The campaign is inviting the companies, which include Abbott Laboratories, GlaxoSmithKline, and Pfizer, to place the patents for a list of HIV drugs into a patent pool recently set up by Unitaid, an international agency that partners with organisations including the World Health Organization and UNAIDS ...
Teaming up with the Redskins and GlaxoSmithKline for this event will bring awareness to a disease that is taking the lives of thousands of men each year and having a significant impact on families. Men over 40 should speak to their healthcare provider to discuss prostate health exams that include both a...
There are no results for this module. Edit the module to change the search term used to query Twitter.
